These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 36897230)

  • 1. Mitochondria-Melanocyte cellular interactions: An emerging mechanism of vitiligo pathogenesis.
    Kaushik H; Kumar V; Parsad D
    J Eur Acad Dermatol Venereol; 2023 Nov; 37(11):2196-2207. PubMed ID: 36897230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endoplasmic Reticulum Dysfunction: An Emerging Mechanism of Vitiligo Pathogenesis.
    Xie Y; Wu N; Tang S; Zhou Z; Chen J; Li J; Wu F; Xu M; Xu X; Liu Y; Ma X
    Clin Cosmet Investig Dermatol; 2024; 17():1133-1144. PubMed ID: 38774812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of repigmentation induced by photobiomodulation therapy in vitiligo.
    Yu S; Lan CE; Yu HS
    Exp Dermatol; 2019 Feb; 28 Suppl 1():10-14. PubMed ID: 30698884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The underestimated role of mitochondria in vitiligo: From oxidative stress to inflammation and cell death.
    Lin Y; Ding Y; Wu Y; Yang Y; Liu Z; Xiang L; Zhang C
    Exp Dermatol; 2024 Jan; 33(1):e14856. PubMed ID: 37338012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced Elastin Fibers and Melanocyte Loss in Vitiliginous Skin Are Restored after Repigmentation by Phototherapy and/or Autologous Minigraft Transplantation.
    Hirobe T; Enami H
    Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible mechanisms of hypopigmentation in lichen sclerosus.
    Carlson JA; Grabowski R; Mu XC; Del Rosario A; Malfetano J; Slominski A
    Am J Dermatopathol; 2002 Apr; 24(2):97-107. PubMed ID: 11979069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in Regenerative Medicine: Repigmentation in Vitiligo Through Melanocyte Stem Cell Mobilization.
    Birlea SA; Costin GE; Roop DR; Norris DA
    Med Res Rev; 2017 Jul; 37(4):907-935. PubMed ID: 28029168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitiligo: where do we stand?
    Ortonne JP; Bose SK
    Pigment Cell Res; 1993 Mar; 6(2):61-72. PubMed ID: 8321867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoimmune destruction of skin melanocytes by perilesional T cells from vitiligo patients.
    van den Boorn JG; Konijnenberg D; Dellemijn TA; van der Veen JP; Bos JD; Melief CJ; Vyth-Dreese FA; Luiten RM
    J Invest Dermatol; 2009 Sep; 129(9):2220-32. PubMed ID: 19242513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melanocyte-keratinocyte cross-talk in vitiligo.
    Touni AA; Shivde RS; Echuri H; Abdel-Aziz RTA; Abdel-Wahab H; Kundu RV; Le Poole IC
    Front Med (Lausanne); 2023; 10():1176781. PubMed ID: 37275386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SIRT3-Dependent Mitochondrial Dynamics Remodeling Contributes to Oxidative Stress-Induced Melanocyte Degeneration in Vitiligo.
    Yi X; Guo W; Shi Q; Yang Y; Zhang W; Chen X; Kang P; Chen J; Cui T; Ma J; Wang H; Guo S; Chang Y; Liu L; Jian Z; Wang L; Xiao Q; Li S; Gao T; Li C
    Theranostics; 2019; 9(6):1614-1633. PubMed ID: 31037127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitiligo.
    Le Poole C; Boissy RE
    Semin Cutan Med Surg; 1997 Mar; 16(1):3-14. PubMed ID: 9125760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New insight into the role of exosomes in vitiligo.
    Wong PM; Yang L; Yang L; Wu H; Li W; Ma X; Katayama I; Zhang H
    Autoimmun Rev; 2020 Nov; 19(11):102664. PubMed ID: 32942029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intelligent bioengineering in vitiligo treatment: transdermal protein transduction of melanocyte-lineage-specific genes.
    Mou Y; Jiang X; Du Y; Xue L
    Med Hypotheses; 2012 Dec; 79(6):786-9. PubMed ID: 22999738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Narrow Band Ultraviolet B Treatment for Human Vitiligo Is Associated with Proliferation, Migration, and Differentiation of Melanocyte Precursors.
    Goldstein NB; Koster MI; Hoaglin LG; Spoelstra NS; Kechris KJ; Robinson SE; Robinson WA; Roop DR; Norris DA; Birlea SA
    J Invest Dermatol; 2015 Aug; 135(8):2068-2076. PubMed ID: 25822579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current Debates on Etiopathogenesis and Treatment Strategies for Vitiligo.
    Chaudhary A; Patel M; Singh S
    Curr Drug Targets; 2022; 23(13):1219-1238. PubMed ID: 35388753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The enigma and challenges of vitiligo pathophysiology and treatment.
    Abdel-Malek ZA; Jordan C; Ho T; Upadhyay PR; Fleischer A; Hamzavi I
    Pigment Cell Melanoma Res; 2020 Nov; 33(6):778-787. PubMed ID: 32198977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skin pigmentation and its control: From ultraviolet radiation to stem cells.
    Yardman-Frank JM; Fisher DE
    Exp Dermatol; 2021 Apr; 30(4):560-571. PubMed ID: 33320376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melanoma-associated leukoderma - immunology in black and white?
    Naveh HP; Rao UN; Butterfield LH
    Pigment Cell Melanoma Res; 2013 Nov; 26(6):796-804. PubMed ID: 24010963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitiligo Pathogenesis and Emerging Treatments.
    Rashighi M; Harris JE
    Dermatol Clin; 2017 Apr; 35(2):257-265. PubMed ID: 28317534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.